UNSPSC 51283958: Sulfisomidine sodium

This classification denotes an anti-infective agent and sulfanilamide C12H13N4O2S.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 296707F7DU, chemically known as sulfisomidine, sodium, but more generally known as sulfisomidine sodium, which bears US NIH Compound Identifier 5343. Most nations, for tariff and trade purposes, schedule sulfisomidine sodium under HS 29350090 and SITC 51580. As of Q4 2014, SULFISOMIDINE SODIUM remains US FDA's Preferred Term for this commodity. SMILES: CC1CC(NC(N1)C)[N-]S(=O)(=O)C2CCC(CC2)N.[NA+].

UNSPSC 51283958 Sulfisomidine sodium is a Commodity code that in recent state and local activity encompasses pharmaceutical procurement spanning naloxone and drug deactivation systems, generic multi-source pharmaceuticals and OTC products, medical and first aid supplies for emergency response, and direct-to-manufacturer prescription programs. State and local buying under this code includes county health departments, state pharmacy benefit programs (particularly through cooperative purchasing vehicles), municipal fire departments, and multi-state purchasing alliances sourcing products for government facilities and health initiatives. The work involves competitive bid solicitations, requests for proposal for framework agreements with manufacturers and wholesalers, and information-gathering RFIs to explore emerging pharmacy contracting models. Vendors must typically meet cGMP and Drug Supply Chain Security Act compliance, maintain specified insurance coverage, provide detailed product information including National Drug Codes and SKUs, and accept performance obligations such as delivery timelines and expiration-date minimums.

Recent activity spans Florida, Texas, and a multi-state region anchored by Minnesota. Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries and a response deadline of July 26, 2026. The Texas Health and Human Services Commission posted RFI HHS0017013 in April 2026 to gather vendor capabilities on direct-to-manufacturer prescription programs serving self-insured employee health plans and state agencies. The City of Tampa's Purchasing Department issued ITB 26P00145 in March 2026 for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, with an estimated contract value of $700,000 and a Small Local Business Enterprise set-aside with a 5% bid discount not to exceed $10,000. The Minnesota Multistate Cooperative Purchasing Alliance issued RFP S1070000015802 in January 2026 for generic multi-source pharmaceuticals and OTC products across participating state and local facilities, with proposals due March 26, 2026 and contract effectiveness targeted for July 1, 2026.